Drug Shortage Report for FLUDARABINE PHOSPHATE FOR INJECTION
| Report ID | 99441 |
| Drug Identification Number | 02283859 |
| Brand name | FLUDARABINE PHOSPHATE FOR INJECTION |
| Common or Proper name | FLUDARABINE PHOSPHATE INJ |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUDARABINE PHOSPHATE |
| Strength(s) | 25MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 2ML |
| ATC code | L01BB |
| ATC description | ANTIMETABOLITES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2019-11-20 |
| Estimated end date | 2020-01-31 |
| Actual end date | 2020-01-08 |
| Shortage status | Resolved |
| Updated date | 2020-01-09 |
| Company comments | Will continue to allocate to 100% of the demand in the market, and will re assess at next replenishment in Jan 2020. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2020-01-09 | French | Compare |
| v5 | 2020-01-09 | English | Compare |
| v4 | 2019-11-22 | French | Compare |
| v3 | 2019-11-22 | English | Compare |
| v2 | 2019-11-21 | French | Compare |
| v1 | 2019-11-21 | English | Compare |
Showing 1 to 6 of 6